Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
Coenzyme Q10 (Q10) is a mitochondrial cofactor and an antioxidant with the potential to combat oxidative stress in heart failure. This study aims to determine the pharmacokinetics of repeated oral dosing of Q10 in Cavalier King Charles Spaniels (CKCS) with spontaneous myxomatous mitral valve disease...
Saved in:
Main Authors: | Liselotte B. Christiansen (Author), Malene K. Morsing (Author), Maria Josefine Reimann (Author), Torben Martinussen (Author), Zita Birlie (Author), Anne Marie V. Schou-Pedersen (Author), Jens Lykkesfeldt (Author), Lisbeth H. Olsen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Depleted Myocardial Coenzyme Q10 in Cavalier King Charles Spaniels with Congestive Heart Failure Due to Myxomatous Mitral Valve Disease
by: Liselotte B. Christiansen, et al.
Published: (2021) -
Myxomatous degeneration of the mitral valve
by: Felippe Lazar Neto, et al.
Published: (2019) -
Reduced cingulate gyrus volume in Cavalier King Charles Spaniels with syringomyelia and neuropathic pain revealed by voxel-based morphometry: a pilot study
by: Björn Nitzsche, et al.
Published: (2023) -
Mitral annulus dynamics in myxomatous mitral valve disease
by: Maria-Magdalena Gurzun, et al.
Published: (2021) -
Effects of Coenzyme Q<sub>10</sub> Supplementation on Oxidative Stress Markers, Inflammatory Markers, Lymphocyte Subpopulations, and Clinical Status in Dogs with Myxomatous Mitral Valve Disease
by: Natalia Druzhaeva, et al.
Published: (2022)